格瑞妥单抗
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
CAS2413817-97-5
Storage conditionShipping with blue ice.
Security information
Product details

Gresonitamab is a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody that targets CD3-positive T cells and CLDN18.2-expressing tumor cells, with potential immunostimulatory and antineoplastic activities. It activates and proliferates T-cells, leading to the lysis of CLDN18.2-expressing tumor cells, Gresonitamab can be used for the research of adenocarcinoma.

Related literature
Related
Sorry, no related items
History
Plerixafor | AMD3100 | JM3100
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Mocravimod hydrochloride (KRP-203)
DOTA-​NHS-ester
PIK-90
CypHer 5
HG-9-91-01 | SIK inhibitor 1
ent-Tadalafil
5-Oxo Rosuvastatin;3-Hydroxy-5-keto Rosuvastatin;Rosuvastatin (R700500) impurity;Rosuvastatin calcium EP Impurity C/(3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid
Amifostine Trihydrate | WR2721 trihydrate